Concessions Mark Solvay Settlement
The U.S. pharmaceutical unit of Belgian chemicals firm Solvay SA has settled a pair of patent-infringement lawsuits with two generic drug makers over a treatment for low testosterone, or "Low T."...To view the full article, register now.
Already a subscriber? Click here to view full article